HIGHLIGHTS
- What: This study evaluated the usefulness of FDG-PET/CT as a screening tool for detecting RCC in patients with end-stage renal disease. This method exploits the lack of physiological FDG accumulation in the urinary tract, and this study showed the potential of this modality in detecting RCC in this patient population.
- Who: Hiromi Hirasawa from the Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, ‑39‑, Showa, Maebashi, Gunma, ‑8511, Japan have published the article: Efficacy of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography for detecting renal cell carcinoma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.